Point72 (DIFC)’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$293K	Buy	+19,767	New	+$293K	0.01%	337
2024 Q3	–	Sell	-21,315	Closed	-$175K	–	1413
2024 Q2	$175K	Buy	+21,315	New	+$175K	0.01%	392